CD8A and gastric cancer: These results indicate that different stages or molecular subtypes of gastric cancer exhibit distinct “Immunosuppressive Barrier with CD8+ T Cell Exhaustion” subtypes in the tumor microenvironment, corresponding to differential therapeutic efficacy and survival outcomes.